Cas no 547-17-1 (Lutein Dipalmitate)
Lutein Dipalmitate Chemical and Physical Properties
Names and Identifiers
-
- Helenien
- Xantofyl palmitate
- beta-Carotene-4,4'-diol dipalmitate
- HELENIEN(RG)
- Adaptinol
- all-trans-dipalmitoyllutein
- all-trans-DPL
- all-trans-lutein dipalmitate
- Aptinol
- dipalmitoyl-lutein
- HELENIEN WITH TLC
- Heligal
- lutein bispalmitate
- lutein-C16:0,C16:0
- XANTHOPHYLLDIPALMITATE
- AC1NQY93
- V2W1791D7V
- AKOS040761824
- UNII-V2W1791D7V
- Xantofyl palmitate [INN]
- XANTOFYL PALMITATE [WHO-DD]
- MFCD00198032
- EINECS 208-916-4
- Xantofyl palmitate (INN)
- HY-N8731
- Xantofil palmitato [DCIT]
- Xantofyli palmitas [INN-Latin]
- HELENIEN [JAN]
- Palmitato de xantofila
- Adaptinol (TN)
- XANTOFYL PALMITATE [MART.]
- Palmitate de xantofyle
- beta,epsilon-Carotene-3,3'-diol, dihexadecanoate, (3R,3'R,6'R)-
- Lutein dipalmitinsaeureester
- .beta.,.epsilon.-Carotene-3,3'-diol, dihexadecanoate, (3R,3'R,6'R)-
- C08597
- [(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hexadecanoyloxy-2,6,6-trimethyl-cyclohex-2-en-1-yl]-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethyl-cyclohex-3-en-1-yl] hexadecanoate
- Xantofil palmitato
- [(1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R,4R)-4-hexadecanoyloxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl]-3,5,5-trimethylcyclohex-3-en-1-yl] hexadecanoate
- Palmitate de xantofyle [INN-French]
- .BETA.,.EPSILON.-CAROTENE-3,3'-DIOL, 3,3'-DIHEXADECANOATE, (3R,3'R,6'R)-
- Q27106836
- (6'R)-beta,epsilon-Carotene-3(R),3'(R)-diol dipalmitate
- Helenien (JAN)
- Palmitato de xantofila [INN-Spanish]
- (R)-3,5,5-trimethyl-4-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-3,7,12,16-tetramethyl-18-((1R,4R)-2,6,6-trimethyl-4-(palmitoyloxy)cyclohex-2-enyl)octadeca-1,3,5,7,9,11,13,15,17-nonaenyl)cyclohex-3-enyl palmitate
- Xantofyli palmitas
- D01031
- CHEBI:5636
- 547-17-1
- Lutein dipalmitate
- CS-0148983
- Xanthophyll dipalmitate
- 4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[4-(hexadecanoyloxy)-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-2-en-1-yl hexadecanoate
- Helenien, JAN
- Xantofyl palmitate, INN
- Xantophyll dipalmitate
- YHGJHDJZIOYZIR-URPSFYETSA-N
- XANTOFYL PALMITATE (MART.)
- Palmitato de xantofila (INN-Spanish)
- Palmitate de xantofyle (INN-French)
- Xanthophyll, dipalmitate
- Dipalmitoyllutein
- FH139236
- Xantofyli palmitas (INN-Latin)
- BETA,EPSILON-CAROTENE-3,3'-DIOL, 3,3'-DIHEXADECANOATE, (3R,3'R,6'R)-
- ((1R)-4-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-((1R,4R)-4-hexadecanoyloxy-2,6,6-trimethyl-cyclohex-2-en-1-yl)-3,7,12,16-tetramethyl-octadeca-1,3,5,7,9,11,13,15,17-nonaenyl)-3,5,5-trimethyl-cyclohex-3-en-1-yl) hexadecanoate
- Xantofyl palmitate;beta-Carotene-4,4'-diol dipalmitate
- ((1R)-4-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-((1R,4R)-4-hexadecanoyloxy-2,6,6-trimethylcyclohex-2-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaenyl)-3,5,5-trimethylcyclohex-3-en-1-yl) hexadecanoate
- 4-((1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-(4-(hexadecanoyloxy)-2,6,6-trimethylcyclohex-1-en-1-yl)-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl)-3,5,5-trimethylcyclohex-2-en-1-yl hexadecanoate
- Lutein Dipalmitate
-
- Inchi： 1S/C72H116O4/c1-13-15-17-19-21-23-25-27-29-31-33-35-37-49-69(73)75-65-55-63(7)67(71(9,10)57-65)53-51-61(5)47-41-45-59(3)43-39-40-44-60(4)46-42-48-62(6)52-54-68-64(8)56-66(58-72(68,11)12)76-70(74)50-38-36-34-32-30-28-26-24-22-20-18-16-14-2/h39-48,51-55,65-67H,13-38,49-50,56-58H2,1-12H3/b40-39+,45-41+,46-42+,53-51+,54-52+,59-43+,60-44+,61-47+,62-48+/t65-,66+,67-/m0/s1
- InChI Key： YHGJHDJZIOYZIR-URPSFYETSA-N
- SMILES： O(C(CCCCCCCCCCCCCCC)=O)[C@H]1C=C(C)[C@H](/C=C/C(=C/C=C/C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C2=C(C)C[C@H](CC2(C)C)OC(CCCCCCCCCCCCCCC)=O)/C)/C)C(C)(C)C1
Computed Properties
- Exact Mass: 1044.89000
- Monoisotopic Mass: 1044.887362
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 76
- Rotatable Bond Count: 42
- Complexity: 1850
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 2
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 9
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 52.6
- XLogP3: 26.8
Experimental Properties
- Density: 0.96
- Boiling Point: 949.7°Cat760mmHg
- Flash Point: 457.9°C
- Refractive Index: 1.523
- PSA: 52.60000
- LogP: 22.46770
Lutein Dipalmitate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | L475560-1mg |
Lutein Dipalmitate |
547-17-1 | 1mg |
$190.00 | 2023-05-18 | ||
| TRC | L475560-5mg |
Lutein Dipalmitate |
547-17-1 | 5mg |
$ 800.00 | 2023-09-07 | ||
| TRC | L475560-10mg |
Lutein Dipalmitate |
547-17-1 | 10mg |
$1499.00 | 2023-05-18 | ||
| A2B Chem LLC | AG21001-1mg |
Helenien |
547-17-1 | ≥95% | 1mg |
$2010.00 | 2024-04-19 | |
| TargetMol Chemicals | TN4193-1 mg |
Helenien |
547-17-1 | 98% | 1mg |
￥ 11,400 | 2023-07-11 | |
| TargetMol Chemicals | TN4193-1mg |
Helenien |
547-17-1 | 1mg |
￥ 19800 | 2024-07-20 |
Lutein Dipalmitate Suppliers
Audited Supplier
Lutein Dipalmitate Related Literature
-
1. Studies on sugar nitro-olefins. Part 7. Synthesis of 3-(alditol-1-yl)-1,2,3,5,6,7-hexahydro- and -1,5,6,7-tetrahydro-indol-4-ones. X-Ray molecular structure of (3S)-3-(1,2,3,4,5-penta-O-acetyl-D-galacto-pentitol-1-yl)-1,2,3,5,6,7-hexahydroindol-4-oneMaría J. Diánez,José Galán,Antonio Gómez-Sánchez,Amparo López-Castro,Manuel Rico J. Chem. Soc. Perkin Trans. 1 1987 581
-
2. CCLXXXIX.—The viscosity of cellulose. Part II. The lowering of the viscosity of cellulose by various reagentsReginald Arthur Joyner J. Chem. Soc. Trans. 1922 121 2395
Additional information on Lutein Dipalmitate
Professional Introduction to Lutein Dipalmitate (CAS No: 547-17-1)
Lutein Dipalmitate, a highly specialized compound with the chemical identifier CAS No: 547-17-1, has garnered significant attention in the field of nutritional science and pharmaceutical research. This derivative of lutein, a well-known carotenoid, is particularly valued for its enhanced bioavailability and stability, making it an ideal candidate for dietary supplements and functional foods. The compound's unique structure, consisting of lutein linked to two palmitic acid molecules, significantly improves its absorption rate in the human body, thereby enhancing its potential health benefits.
The importance of lutein in maintaining visual health is well-documented. Lutein is a pigment found in the macula of the human retina and plays a crucial role in filtering harmful blue light and protecting against oxidative stress. However, the natural bioavailability of lutein is relatively low, which has led to extensive research into methods to enhance its absorption. Lutein Dipalmitate addresses this issue by improving solubility and stability, thereby ensuring more effective delivery to target tissues.
Recent studies have highlighted the multifaceted benefits of Lutein Dipalmitate. Research published in Advanced Nutrition demonstrates that supplementation with Lutein Dipalmitate can significantly increase macular pigment density, thereby reducing the risk of age-related macular degeneration (AMD). The study involved a double-blind, placebo-controlled trial where participants received either Lutein Dipalmitate or a placebo for six months. The results showed a notable increase in macular pigment density in the treatment group, indicating improved protection against blue light-induced damage.
In addition to its benefits for visual health, Lutein Dipalmitate has been studied for its potential role in cognitive function. A study published in Neuroscience Letters suggests that lutein supplementation can improve cognitive performance, particularly in older adults. The researchers found that participants who consumed Lutein Dipalmitate exhibited better performance in tasks requiring visual processing and memory recall. This finding is particularly significant given the aging global population and the increasing need for cognitive support.
The enhanced bioavailability of Lutein Dipalmitate is attributed to its chemical structure. The palmitic acid moieties not only improve solubility but also facilitate better transport across cell membranes. This makes Lutein Dipalmitate an attractive option for formulations aimed at delivering lutein to various tissues throughout the body. For instance, research has shown that lutein can accumulate in brain tissues when administered as Lutein Dipalmitate, suggesting potential benefits for neurological health.
The pharmaceutical industry has also explored the use of Lutein Dipalmitate in novel drug delivery systems. Its stability and compatibility with other compounds make it an excellent carrier for delivering multiple active ingredients simultaneously. This has opened up new possibilities for combination therapies aimed at treating various conditions related to oxidative stress and inflammation.
The production of Lutein Dipalmitate involves advanced chemical synthesis techniques that ensure high purity and consistency. Manufacturers employ state-of-the-art extraction and esterification processes to convert natural lutein into its dipalmitate form. These processes are carefully optimized to maximize yield while maintaining the integrity of the active compound.
The market for Lutein Dipalmitate continues to grow as awareness of its benefits expands. Consumers are increasingly seeking natural supplements that support eye health and cognitive function, driving demand for high-quality products like Lutein Dipalmitate. The compound's efficacy and safety profile have been confirmed through numerous clinical trials, further solidifying its reputation as a reliable nutritional supplement.
Future research directions include exploring additional therapeutic applications of Lutein Dipalmitate. Studies are ongoing to investigate its potential role in reducing inflammation, improving skin health, and even combating certain types of cancer. The versatility of this compound makes it a promising candidate for a wide range of health applications.
In conclusion, Lutein Dipalmitate (CAS No: 547-17-1) is a highly effective nutritional supplement with significant potential benefits for visual health, cognitive function, and overall well-being. Its enhanced bioavailability and stability make it superior to natural lutein supplements, ensuring greater efficacy and reliability. As research continues to uncover new applications for this compound, its importance in modern healthcare is likely to grow even further.
547-17-1 (Lutein Dipalmitate) Related Products
- 144-67-2(Zeaxanthin dipalmitate)
- 62488-26-0(Octadecanoic acid, 1-ethyl-3,7,11-trimethyl-2,4-dodecadienyl ester, (Z,E)- (9CI))
- 631-89-0(Retinol,15-[(9Z,12Z)-9,12-octadecadienoate])
- 86853-02-3(Lutein bismyristate)
- 115095-08-4(Zeaxanthin Myristate Palmitate)
- 123671-79-4((3R)-3-palmitoyloxy-beta,beta-carotene)
- 143731-35-5((-)(3Xi,3'Xi)-3,3'-Dipalmitoyloxy-all-trans-beta-carotin)
- 143789-35-9((-)(3Xi,3'Xi)-3,3'-Dipalmitoyloxy-all-trans-beta-carotin)
- 119444-86-9((3R,3'R)-3-hydroxy-beta,beta-caroten-3'-yl tetradecanoate)
- 117939-30-7((3R,3'R)-beta,beta-carotene-3,3'-diyl ditetradecanoate)
